Dr. Chu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Vientiane
Lao PDR
Saint Louis, MO 63132
Education & Training
OPEN UniversityPhD, Life Sciences, 2010 - 2016- Saint Louis UniversityMasters, Public Health, 2004 - 2006
Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Internal Medicine/Pediatrics, 1997 - 2001- Case Western Reserve Univ/Univ Hosps Cleveland Med Ctr/Rainbow Babies and Childrens HospitalResidency, Pediatrics, 1996 - 1997
University of Missouri Kansas City School of MedicineClass of 1996
Certifications & Licensure
MO State Medical License 2003 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Pediatrics Pediatrics
Clinical Trials
- Southeast Asia Dose Optimization of Tafenoquine Start of enrollment: 2024 Aug 01
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 74 citationsPrimaquine‑Induced Haemolysis in Females Heterozygous for G6PD DeficiencyCindy S. Chu, Germana Bancone, François Nosten, Nicholas J. White, Lucio Luzzatto
Malaria Journal. 2018-03-02 - 21 citationsThe suitability of laboratory-bred Anopheles cracens for the production of Plasmodium vivax sporozoitesChiara Andolina, Jordi Landier, Verena I. Carrara, Cindy S. Chu, Jean François Franetich
Malaria Journal. 2015-08-12
Press Mentions
A PLOS Medicine Collection on Plasmodium Vivax--a Neglected Cause of MalariaApril 23rd, 2021
Anti‐Malarial Drug Effects on Parasite Dynamics in Vivax MalariaMarch 21st, 2021
Grant Support
- Southeast Asia Dose Optimization of Tafenoquine (SEADOT)NIH/NIAID2023–2028
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
